Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia

• 主要な著者: Tatyana I. Lokteva (著者), l'ya S. Rozhkov (著者), Vladimir V. Gureev (著者), Anastasia V. Gureeva (著者), Marija A. Zatolokina (著者), Elena V. Avdeeva (著者), Lyudmila A. Zhilinkova (著者), Evgenij E. Prohoda (著者), Elizoveta O. Yarceva (著者)
• フォーマット: 図書
• 出版事項: Belgorod National Research University, 2020-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Introduction: Preeclampsia remains one of the most common causes of maternal and perinatal mortality worldwide. A significant role in the pathogenesis of this pathology is assigned to placental ischemia and endothelial dysfunction. Therefore, the aim of the present study was to study the effectivene...